search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Tailored cognitive-behavioral E-health care in patients with psoriasis.


- candidate number8274
- NTR NumberNTR2436
- ISRCTNISRCTN wordt niet meer aangevraagd.
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR30-jul-2010
- Secondary IDsWS682746 Radboud University Nijmegen
- Public TitleTailored cognitive-behavioral E-health care in patients with psoriasis.
- Scientific TitleTailored cognitive-behavioral E-health care in patients with psoriasis.
- ACRONYME-health Psoriasis
- hypothesisThe aim of the study is to show the effectiveness of tailored cognitive-behavioral E-health care for risk groups of patients with psoriasis in comparison to usual care.
- Healt Condition(s) or Problem(s) studiedPsoriasis
- Inclusion criteria1. Diagnosis of definite psoriasis;
2. Age above 18 years.
- Exclusion criteria1. Pregnancy;
2. Illiteracy;
3. Severe physical and/or psychiatric comorbidity that interfere with the study protocol;
4. Current psychological treatments.
- mec approval receivedyes
- multicenter trialno
- randomisedyes
- masking/blindingNone
- controlActive
- groupParallel
- Type2 or more arms, randomized
- Studytypeintervention
- planned startdate 1-jun-2010
- planned closingdate1-jun-2013
- Target number of participants130
- InterventionsThe intervention of E-health tailored cognitive-behavioral therapy consists of tailored individual treatments with E-health treatment modules that target the most frequently experienced problems which psoriasis patients have to cope with, including coping with itch, fatigue, negative mood and social relationships. Choice of E-health treatment modules are determined based on patient priorities and therapist judgments. All E-health treatment modules consist of cognitive and behavioral elements with homework assignments of about half an hour per day. In all treatment modules, the final booster session deals with relapse prevention and further improvement of the attained goals. For the E-health application, patients have mail contact with the therapist at least once a week. Duration of the treatment is about 6 months.

Patients in the control group will receive standard psoriasis care without E-health or face-to-face tailored cognitive-behavioral care.
- Primary outcomeThe primary outcome is the impact of psoriasis on daily life, including its impact on physical and psychological functioning and daily activities at post-treatment and follow-up measurement at 12 months.

The primary outcome measures are measured as follows:
1. Impact on daily life: Composite scores of:
A. Itch (IHDL, Evers et al., 2007);
B. Fatigue (CIS, Vercoulen et al., 1994).
2. Impact on psychological functioning: Composite scores of:
A. Negative mood (IHDL, Evers et al., 2007);
B. Anxiety (IHDL, Evers et al., 2007);
C. Depression (BDI, Beck et al., 1988).
3. Impact on daily activities:
A. Role limitations due to emotional and physical health problems (SF-36, Ware et al., 1993).
- Secondary outcomeSecondary outcomes include effects on disease severity as well as compliance with regular care and health care use.
- TimepointsFor the treatment group, assessments take place before and after treatment (ca. 6 months later) and at the follow-up measurement 12 months after pre-treatment. For the control group, assessments take place at 0, 6, and 12 months.
- Trial web siteN/A
- statusopen: patient inclusion
- CONTACT FOR PUBLIC QUERIESProf. Dr. A.W.M. Evers
- CONTACT for SCIENTIFIC QUERIESProf. Dr. A.W.M. Evers
- Sponsor/Initiator Radboud University Medical Center Nijmegen
- Funding
(Source(s) of Monetary or Material Support)
Wyeth
- PublicationsN/A
- Brief summaryIn the present project, the effects of tailored E-health cognitive behavioral care are studied for patients with psoriasis. In a randomized controlled trial, psoriasis patients are screened for psychological risk profiles. Patients at risk will be randomized to an E-health cognitive-behavioral treatment or a control condition with care as usual. It is expected that the E-health cognitive-behavioral care will be effective for the impact of the disease on physical and psychological functioning and daily activities at post-treatment and at the follow-up assesment. Secondary outcomes include effects on disease severity as well as compliance with regular care and health care use.
- Main changes (audit trail)13-Mar-2013: Timepoints have changed - NM
Due to variable duration of treatment length, follow- assessments were anchored on the post-treatment assessment instead of on the pre-treatment assessment for all participants: For the treatment group, assessments take place before and after treatment and at the follow-up measurement 6 months after post-treatment. For the control group, assessments take place at 0, 6, and 12 months.
- RECORD30-jul-2010 - 19-mrt-2013


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl